Given anti-inflammatory properties of the normal endothelium, this concept is also concordant with a joint synergistic contribution of higher hs-CRP and peripheral microvascular endothelial dysfunction, but not IR, to the risk of new-onset type 2 diabetes [5]. The gene discussed is MAP3K14; the disease is type 2 diabetes mellitus.